Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

CureVac B.V.

5.40
0.0000
Pre-market: 5.38-0.0200-0.37%06:29 EDT
Volume:512.13K
Turnover:2.77M
Market Cap:1.22B
PE:5.37
High:5.42
Open:5.42
Low:5.38
Close:5.40
52wk High:5.72
52wk Low:2.37
Shares:225.17M
Float Shares:125.87M
Volume Ratio:1.00
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.01
EPS(LYR):0.7483
ROE:40.22%
ROA:23.77%
PB:1.79
PE(LYR):7.22

Loading ...

OverviewCompanyNewsFilings

CureVac's Q2 Pre-Tax Loss Narrows, Revenue Falls

MT Newswires Live
·
Aug 15

CureVac Nv: Q2 REV €1.2 Million

THOMSON REUTERS
·
Aug 15

CureVac Nv: Company Reaffirms Its Expected Cash Runway Into 2028

THOMSON REUTERS
·
Aug 15

Earnings Flash (CVAC) CureVac Posts Q2 Revenue 1.2M Euros, vs. FactSet Est of 3.3M Euros

MT Newswires Live
·
Aug 15

CureVac Reports Decrease in Net Financial Result for H1 2025; R&D Expenses Rise Amid Strategic Restructuring

Reuters
·
Aug 15

CureVac NV expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
Aug 11

BioNTech, Pfizer, and CureVac Settle COVID-19 Vaccine Patent Dispute in the U.S., Establish Global Framework

Reuters
·
Aug 11

Top Midday Stories: Trade Desk CEO Says Tariffs Impacting Key Clients; UK Regulator Approves Boeing's Acquisition of Spirit AeroSystems

MT Newswires Live
·
Aug 08

CureVac Resolves Patent Litigation with Pfizer/BioNTech, Receives $740 Million Settlement

Reuters
·
Aug 08

CureVac Nv - CureVac and GSK Will Receive in Aggregate a Payment of $740 Mln

THOMSON REUTERS
·
Aug 08

CureVac-Will Grant BioNTech and Pfizer Non-Exclusive License to Manufacture, Use, Import Into U.S. and Sell Mrna-Based Covid-19 and Influenza Products

THOMSON REUTERS
·
Aug 08

BUZZ-DB expects EU pharma 'malaise' to continue amid US headwinds

Reuters
·
Jul 08

CureVac NV Conducted Its Annual General Meeting of Shareholders

Reuters
·
Jun 27

Curevac Cut to Neutral From Buy by UBS

Dow Jones
·
Jun 26

UBS Downgrades CureVac to Neutral From Buy, Adjusts Price Target to $5.50 From $12

MT Newswires Live
·
Jun 26

UBS downgrades CureVac (CVAC) to a Hold

TIPRANKS
·
Jun 26

CureVac NV Held Annual General Meeting

Reuters
·
Jun 25

BRIEF-CureVac agrees to pay Biontech termination fee Of $43.8 mln under specified circumstances

Reuters
·
Jun 17

CureVac NV Announces Purchase Agreement with BioNTech SE as of June 12, 2025

Reuters
·
Jun 17

Jefferies Downgrades CureVac to Hold From Buy, $5 Price Target

MT Newswires Live
·
Jun 13
More